Megasoft (BOM:532408) Debt-to-EBITDA : 5.95 (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Megasoft Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Megasoft's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹97.11 Mil. Megasoft's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹1,373.36 Mil. Megasoft's annualized EBITDA for the quarter that ended in Mar. 2024 was ₹247.03 Mil. Megasoft's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 5.95.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Megasoft's Debt-to-EBITDA or its related term are showing as below:

BOM:532408' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.64 Med: 4.25 Max: 7.15
Current: 5.16

During the past 13 years, the highest Debt-to-EBITDA Ratio of Megasoft was 7.15. The lowest was 2.64. And the median was 4.25.

BOM:532408's Debt-to-EBITDA is ranked worse than
80.03% of 656 companies
in the Drug Manufacturers industry
Industry Median: 1.715 vs BOM:532408: 5.16

Megasoft Debt-to-EBITDA Historical Data

The historical data trend for Megasoft's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft Debt-to-EBITDA Chart

Megasoft Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-EBITDA

Get a 7-Day Free Trial

3.71

3.42

2.64

5.81

5.16

Megasoft Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial															4.48	-	4.45	-	5.95

Competitive Comparison of Megasoft's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Megasoft's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Megasoft's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Megasoft's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Megasoft's Debt-to-EBITDA falls into.

Megasoft Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Megasoft's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(97.108	+	1373.362)	/	284.731
	=	5.16

Megasoft's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(97.108	+	1373.362)	/	247.032
	=	5.95

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.

Megasoft (BOM:532408) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Megasoft Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Megasoft's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Megasoft (BOM:532408) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (BOM:532408) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

MEGASOFT:India

Address

Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081

Website

http://www.megasoft.com

Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft (BOM:532408) Headlines

No Headlines